Considering that IL-4/IL-13 and IFN-γ/IL-12 counter regulate each other, our finding that IL-13 is protective is in line with the previous observation that IFN-γ and IL-12 can be tumor-promoting in DMBA/TPA carcinogenesis [15–17]. The gene discussed is IL13; the disease is neoplasm.